Growth Metrics

Tango Therapeutics (TNGX) Shares Issued (2020 - 2024)

Historic Shares Issued for Tango Therapeutics (TNGX) over the last 5 years, with Q1 2024 value amounting to $41.7 million.

  • Tango Therapeutics' Shares Issued rose 5705479.45% to $41.7 million in Q1 2024 from the same period last year, while for Sep 2024 it was $41.8 million, marking a year-over-year change of. This contributed to the annual value of $689000.0 for FY2023, which is N/A changed from last year.
  • As of Q1 2024, Tango Therapeutics' Shares Issued stood at $41.7 million, which was up 5705479.45% from $73000.0 recorded in Q1 2023.
  • Over the past 5 years, Tango Therapeutics' Shares Issued peaked at $166.8 million during Q3 2020, and registered a low of $25000.0 during Q2 2020.
  • Moreover, its 5-year median value for Shares Issued was $352000.0 (2021), whereas its average is $47.0 million.
  • As far as peak fluctuations go, Tango Therapeutics' Shares Issued tumbled by 9993.94% in 2021, and later skyrocketed by 5705479.45% in 2024.
  • Quarter analysis of 5 years shows Tango Therapeutics' Shares Issued stood at $166.8 million in 2020, then tumbled by 99.94% to $101000.0 in 2021, then soared by 162.38% to $265000.0 in 2022, then crashed by 72.45% to $73000.0 in 2023, then soared by 57054.79% to $41.7 million in 2024.
  • Its last three reported values are $41.7 million in Q1 2024, $73000.0 for Q1 2023, and $265000.0 during Q1 2022.